About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 156356, 9 pages
http://dx.doi.org/10.1155/2014/156356
Research Article

Durable Expression of Minicircle DNA-Liposome-Delivered Androgen Receptor cDNA in Mice with Hepatocellular Carcinoma

1Sex Hormone Research Center, Center for Molecular Medicine, and Organ Transplantation Center, China Medical University Hospital, Taichung 404, Taiwan
2Graduate Institution of Clinical Medical Science, Department of Medicine, School of Medicine, China Medical University, Taichung 404, Taiwan
3Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

Received 4 September 2013; Revised 25 December 2013; Accepted 21 January 2014; Published 6 March 2014

Academic Editor: Guillermo Mazzolini

Copyright © 2014 Tian-You Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 271–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Maeda, “SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy,” Advanced Drug Delivery Reviews, vol. 46, no. 1–3, pp. 169–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Vasey, S. B. Kaye, R. Morrison et al., “Phase I clinical and pharmacokinetic study of PK1 [N-(2- hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates,” Clinical Cancer Research, vol. 5, no. 1, pp. 83–94, 1999. View at Scopus
  4. F. Liu, Y. K. Song, and D. Liu, “Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA,” Gene Therapy, vol. 6, no. 7, pp. 1258–1266, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Gao, K.-S. Kim, and D. Liu, “Nonviral gene delivery: what we know and what is next,” AAPS Journal, vol. 9, no. 1, article 9, pp. E92–E104, 2007. View at Scopus
  6. C. H. Miao, A. R. Thompson, K. Loeb, and X. Ye, “Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo,” Molecular Therapy, vol. 3, no. 6, pp. 947–957, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. H. Miao, X. Ye, and A. R. Thompson, “High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors,” Human Gene Therapy, vol. 14, no. 14, pp. 1297–1305, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Jiang, E. Yamato, and J.-I. Miyazaki, “Intravenous delivery of naked plasmid DNA for in vivo cytokine expression,” Biochemical and Biophysical Research Communications, vol. 289, no. 5, pp. 1088–1092, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Yang, S. Chen, L. Huang, G. K. Michalopoulos, and Y. Liu, “Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth,” Hepatology, vol. 33, no. 4, pp. 848–859, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. F. Aliño, A. Crespo, and F. Dasí, “Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA,” Gene Therapy, vol. 10, no. 19, pp. 1672–1679, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. Ortaldo, R. T. Winkler-Pickett, E. W. Bere Jr., M. Watanabe, W. J. Murphy, and R. H. Wiltrout, “In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells,” Journal of Immunology, vol. 175, no. 2, pp. 693–699, 2005. View at Scopus
  12. T. Suda and D. Liu, “Hydrodynamic gene delivery: its principles and applications,” Molecular Therapy, vol. 15, no. 12, pp. 2063–2069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Krieg, “Direct immunologic activities of CpG DNA and implications for gene therapy,” Journal of Gene Medicine, vol. 1, no. 1, pp. 56–63, 1999. View at Scopus
  14. G. McLachlan, B. J. Stevenson, D. J. Davidson, and D. J. Porteous, “Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs,” Gene Therapy, vol. 7, no. 5, pp. 384–392, 2000. View at Scopus
  15. Z.-Y. Chen, C.-Y. He, A. Ehrhardt, and M. A. Kay, “Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo,” Molecular Therapy, vol. 8, no. 3, pp. 495–500, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. N. S. Yew, H. Zhao, M. Przybylska et al., “CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo,” Molecular Therapy, vol. 5, no. 6, pp. 731–738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. L. Felgner, T. R. Gadek, M. Holm et al., “Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 21, pp. 7413–7417, 1987. View at Scopus
  18. D. Liu, T. Ren, and X. Gao, “Cationic transfection lipids,” Current Medicinal Chemistry, vol. 10, no. 14, pp. 1307–1315, 2003. View at Scopus
  19. T. Merdan, J. Kopeček, and T. Kissel, “Prospects for cationic polymers in gene and oligonucleotide therapy against cancer,” Advanced Drug Delivery Reviews, vol. 54, no. 5, pp. 715–758, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Gao and L. Huang, “Potentiation of cationic liposome-mediated gene delivery by polycations,” Biochemistry, vol. 35, no. 3, pp. 1027–1036, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-D. Li, S. Chono, and L. Huang, “Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles,” Journal of Controlled Release, vol. 126, no. 1, pp. 77–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-D. Li, Y.-C. Chen, M. J. Hackett, and L. Huang, “Tumor-targeted delivery of siRNA by self-assembled nanoparticles,” Molecular Therapy, vol. 16, no. 1, pp. 163–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-D. Li and L. Huang, “Nanoparticles evading the reticuloendothelial system: role of the supported bilayer,” Biochimica et Biophysica Acta, vol. 1788, no. 10, pp. 2259–2266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Chang, J. Kokontis, and S. Liao, “Molecular cloning of human and rat complementary DNA encoding androgen receptors,” Science, vol. 240, no. 4850, pp. 324–326, 1988. View at Scopus
  25. C.-L. Ma, C.-L. Hsu, M.-H. Wu et al., “Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma,” Gastroenterology, vol. 135, no. 3, pp. 947–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-H. Wu, W.-L. Ma, C.-L. Hsu et al., “Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription,” Science Translational Medicine, vol. 2, no. 32, article 32ra35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. W. L. Ma, C. L. Hsu, C. C. Yeh et al., “Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis,” Hepatology, vol. 56, pp. 176–185, 2012.
  28. Y. Zheng, W.-L. Chen, S. G. Louie, T. S. B. Yen, and J.-H. J. Ou, “Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice,” Hepatology, vol. 45, no. 1, pp. 16–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Kay, C.-Y. He, and Z.-Y. Chen, “A robust system for production of minicircle DNA vectors,” Nature Biotechnology, vol. 28, no. 12, pp. 1287–1289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Zheng, J. Li, and J.-H. Ou, “Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein,” Journal of Virology, vol. 78, no. 13, pp. 6908–6914, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Li, Z. Xu, Y. Zheng, D. L. Johnson, and J.-H. Ou, “Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins,” Journal of Virology, vol. 76, no. 12, pp. 5875–5881, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. R. E. Kingston, C. A. Chen, and J. K. Rose, “Calcium phosphate transfection,” in Current Protocols in Molecular Biology, F. M. Ausubel, Ed., chapter 9, unit 9 1, 2003.
  33. C. Mah, B. J. Byrne, and T. R. Flotte, “Virus-based gene delivery systems,” Clinical Pharmacokinetics, vol. 41, no. 12, pp. 901–911, 2002. View at Scopus
  34. M. T. Lotze and T. A. Kost, “Viruses as gene delivery vectors: application to gene function, target validation, and assay development,” Cancer Gene Therapy, vol. 9, no. 8, pp. 692–699, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-H. H. Lien and L.-W. Lai, “Gene therapy for renal disorders: what are the benefits for the elderly?” Drugs and Aging, vol. 19, no. 8, pp. 553–560, 2002. View at Scopus
  36. D. J. Wells, A. Ferrer, and K. E. Wells, “Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy,” Expert Reviews in Molecular Medicine, vol. 4, pp. 1–23, 2002.
  37. J. K. Wolf and A. D. Jenkins, “Gene therapy for ovarian cancer (review),” International Journal of Oncology, vol. 21, no. 3, pp. 461–468, 2002. View at Scopus
  38. B. Sangro, G. Mazzolini, M. Ruiz et al., “A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma,” Cancer Gene Therapy, vol. 17, no. 12, pp. 837–843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Tian, J. Liu, J. S. R. Zhou, and W. Chen, “Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial,” Anti-Cancer Drugs, vol. 20, no. 5, pp. 389–395, 2009. View at Scopus
  40. M. A. Kay, J. C. Glorioso, and L. Naldini, “Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics,” Nature Medicine, vol. 7, no. 1, pp. 33–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. T. L. Timme, S. J. Hall, R. Barrios, S. L. C. Woo, E. Aguilar-Cordova, and T. C. Thompson, “Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice,” Cancer Gene Therapy, vol. 5, no. 2, pp. 74–82, 1998. View at Scopus
  42. L. Tenenbaum, E. Lehtonen, and P. E. Monahan, “Evaluation of risks related to the use of adeno-associated virus-based vectors,” Current Gene Therapy, vol. 3, no. 6, pp. 545–565, 2003. View at Scopus
  43. T. R. Flotte and B. L. Laube, “Gene therapy in cystic fibrosis,” Chest, vol. 120, no. 3, pp. 124S–131S, 2001. View at Scopus
  44. S. E. Raper, N. Chirmule, F. S. Lee et al., “Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer,” Molecular Genetics and Metabolism, vol. 80, no. 1-2, pp. 148–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. D. Patil, D. G. Rhodes, and D. J. Burgess, “DNA-based therapeutics and DNA delivery systems: a comprehensive review,” The AAPS Journal, vol. 7, no. 1, article 9, pp. E61–E77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. C. Leroux, and J. P. Benoit, “Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake,” Journal of Biomedical Materials Research A, vol. 78, no. 3, pp. 620–628, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. K. Song, “Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration,” Human Gene Therapy, vol. 8, no. 13, pp. 1585–1594, 1997. View at Scopus
  48. N. S. Yew and R. K. Scheule, “Toxicity of cationic lipid-DNA complexes,” Advances in Genetics, vol. 53, pp. 189–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. N. S. Yew, K. X. Wang, M. Przybylska et al., “Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes,” Human Gene Therapy, vol. 10, no. 2, pp. 223–234, 1999. View at Publisher · View at Google Scholar · View at Scopus